Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

IKTIKT
7 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in INHIBIKASE THERAPEUTICS INC

NORTHERN TRUST CORP holds 878,585 shares of IKT (INHIBIKASE THERAPEUTICS INC), worth $1.8M as of 2026-Q2. The position was increased (+22.2% shares). IKT represents 0.0% of NORTHERN TRUST CORP's portfolio.

Current Value

$1.8M

Current Shares

878,585

Total Value Change

+$1.6M

Total Shares Change

+814,574

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
878,585
+22.2%
$1.8M0.0%$2.03
31
2026-Q1
Increased
718,800
+122.7%
$1.2M0.0%$1.91
41
2025-Q4
Decreased
322,720
-13.8%
$661,5760.0%$1.97
0
2025-Q3
Decreased
374,336
-4.7%
$606,4240.0%$1.53
0
2025-Q2
Increased
392,716
+513.5%
$765,7960.0%$1.62
40
2025-Q1
Unchanged
64,011
0.0%
$140,1840.0%$2.29
0
2024-Q4
New
64,011
-
$208,0360.0%$3.24
35

Other major holders of IKT: BlackRock, Inc., Blackstone Inc., VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used